InProTher

12:15 PM - 12:30 PM, Tuesday, June 4,2019 ・ SuS - Hall E, Booth 3971, Level 200
Research company focused on developing vaccine technology and improving cancer treatments by targeting tumor viruses within the human genome in an effort to provide effective vaccines and improved treatments to patients. The company anticipates a growth in funding and starting clinical trials through collaboration with clinical experts to develop an effective treatment for cancer.
Speaker
photo
CEO and CSO
InProTher